Zinc finger protein 91 (ZFP91) activates HIF-1α via NF-κB/p65 to promote proliferation and tumorigenesis of colon cancer

Oncotarget

Volumn 7, Issue 24, 2016, Pages 36551-36562

  Ma, Juan ^a   Mi, Chunliu ^a   Wang, Ke Si ^a   Lee, Jung Joon ^a   Jin, Xuejun ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

Colon cancer; HIF 1 ; NF B p65; Tumorigenesis; ZFP91

Indexed keywords

EDOXUDINE; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 91; PROTEIN BINDING; UBIQUITIN PROTEIN LIGASE; ZFP91 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CASE REPORT; CHROMATIN IMMUNOPRECIPITATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; HIF 1ALPHA GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TUMOR XENOGRAFT; UPREGULATION; ZFP91 GENE; AGED; ANIMAL; BAGG ALBINO MOUSE; CARCINOGENESIS; CELL PROLIFERATION; COLON TUMOR; GENETICS; HCT 116 CELL LINE; MALE; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; XENOGRAFT;

AGED; ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA INTERFERENCE; TRANSCRIPTION FACTOR RELA; TRANSPLANTATION, HETEROLOGOUS; UBIQUITIN-PROTEIN LIGASES;

EID: 84978134352     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.9070     Document Type: Article

References (38)

1. Saotome Y, Winter CG and Hirsh D. A widely expressed novel C2H2 zinc-finger protein with multiple consensus phosphorylation sites is conserved in mouse and man. Gene. 1995; 152:233-238.
2. Tompkins V, Hagen J, Zediak VP and Quelle DE. Identification of novel ARF binding proteins by two-hybrid screening. Cell Cycle. 2006; 5:641-646.
3. Unoki M, Okutsu J and Nakamura Y. Identification of a novel human gene, ZFP91, involved in acute myelogenous leukemia. Int J Oncol. 2003; 22:1217-1223.
4. Paschke L, Rucinski M, Ziolkowska A, Zemleduch T, Malendowicz W, Kwias Z and Malendowicz LK. ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology. Pathol Oncol Res. 2014; 20:453-459.
5. Jin X, Jin HR, Jung HS, Lee SJ, Lee JH and Lee JJ. An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitination. J Biol Chem. 2010; 285:30539-30547.
6. Jin HR, Jin X and Lee JJ. Zinc-finger protein 91 plays a key role in LIGHT-induced activation of non-canonical NF-kappaB pathway. Biochem Biophys Res Commun. 2010; 400:581-586.
7. Wilson WR and Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011; 11:393-410.
8. Wang GL and Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995; 270:1230-1237.
9. Nagaraju GP, Bramhachari PV, Raghu G and El-Rayes BF. Hypoxia inducible factor-1alpha: Its role in colorectal carcinogenesis and metastasis. Cancer letters. 2015; 366:11-18.
10. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M and Chayama K. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer. 2003; 105:176-181.
11. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda). 2004; 19:176-182.
12. Yee Koh M, Spivak-Kroizman TR and Powis G. HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci. 2008; 33:526-534.
13. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3:721-732.
14. Wang GL, Jiang BH, Rue EA and Semenza GL. Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995; 92:5510-5514.
15. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG and Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008; 453:807-811.
16. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T and Gorlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol. 2007; 27:755-761.
17. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T and Gorlach A. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Mol Biol Cell. 2007; 18:4691-4697.
18. Mak P, Li J, Samanta S and Mercurio AM. ERbeta regulation of NF-κB activation in prostate cancer is mediated by HIF-1. Oncotarget. 2015; 6:40247-54. doi: 10.18632/oncotarget.5377.
19. van Uden P, Kenneth NS and Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J. 2008; 412:477-484.
20. Gorlach A and Bonello S. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison. Biochem J. 2008; 412:e17-19.
21. Yoshida T, Hashimura M, Mastumoto T, Tazo Y, Inoue H, Kuwata T and Saegusa M. Transcriptional upregulation of HIF-1alpha by NF-kappaB/p65 and its associations with beta-catenin/p300 complexes in endometrial carcinoma cells. Lab Invest. 2013; 93:1184-1193.
22. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 1999; 59:5830-5835.
23. Jung CR, Hwang KS, Yoo J, Cho WK, Kim JM, Kim WH and Im DS. E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med. 2006; 12:809-816.
24. Ortmann B, Druker J and Rocha S. Cell cycle progression in response to oxygen levels. Cell Mol Life Sci. 2014; 71:3569-3582.
25. Ting AH, McGarvey KM and Baylin SB. The cancer epigenome- components and functional correlates. Genes Dev. 2006; 20:3215-3231.
26. Ponder BA. Cancer genetics. Nature. 2001; 411:336-341.
27. Lee JJ LJ, Lee K, Hong Y-S, Jin X. Therapeutic agent for cancer, inflammation, and auto-immune disease containing inhibitor of Zinc Finger Protein 91. US Patent 20, 080, 248, 024. 2008.
28. Qu LL, He L, Zhao X and Xu W. Downregulation of miR-518a-3p activates the NIK-dependent NF-kappaB pathway in colorectal cancer. Int J Mol Med. 2015; 35:1266-1272.
29. Uno M, Saitoh Y, Mochida K, Tsuruyama E, Kiyono T, Imoto I, Inazawa J, Yuasa Y, Kubota T and Yamaoka S. NF-kappaB inducing kinase, a central signaling component of the non-canonical pathway of NF-kappaB, contributes to ovarian cancer progression. PLoS One. 2014; 9:e88347.
30. Thu YM and Richmond A. NF-kappaB inducing kinase: a key regulator in the immune system and in cancer. Cytokine Growth Factor Rev. 2010; 21:213-226.
31. Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, Mino-Kenduson M, Lynch MP, Rueda BR, Benita Y, Xavier RJ and Chung DC. HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer. 2009; 124:763-771.
32. Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012; 33:207-214.
33. Mabjeesh NJ and Amir S. Hypoxia-inducible factor (HIF) in human tumorigenesis. Histol Histopathol. 2007; 22:559-572.
34. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 29:625-634.
35. Liao D, Corle C, Seagroves TN and Johnson RS. Hypoxiainducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 2007; 67:563-572.
36. Hoffmann A and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev. 2006; 210:171-186.
37. Chariot A. 20 years of NF-kappaB. Biochem Pharmacol. 2006; 72:1051-1053.
38. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA and Weinberg RA. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol. 2002; 22:2111-2123.